Literature DB >> 15347835

The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2.

Rafael Oliva1, Anna Novials, Mayka Sánchez, Marga Villa, Mercedes Ingelmo, Mónica Recasens, Carlos Ascaso, Miquel Bruguera, Ramón Gomis.   

Abstract

We initiated the present work to determine whether the presence of the HFE C282Y or H63D mutations could be related to the clinical expression of diabetes mellitus type 2. Two hundred and twenty five type 2 consecutive diabetic patients were included and the HFE genotypes were determined. Younger ages of onset of diabetes as well as a longer duration of the disease were detected in patients carrying at least one C282Y allele (p = 0.007). An increased prevalence of retinopathy (p = 0.014) and of nephropathy (p = 0.04) were also detected in individuals carrying at least one C282Y allele in comparison with patients carrying the other alleles. The increased prevalence of retinopathy in C282Y carriers is related to the increased duration of the disease, but we not have detected that the prevalence of nephropathy is associated with the duration of the disease. However, multivariate logistic regression confirms that the prevalence of nephropathy is higher in the group of patients carrying at least one C282Y allele or the H63D/H63D genotype as compared to the group of patients with the wild-type (N/N) or the N/H63D genotype. To our knowledge our study is the first one to report an earlier age of onset in type 2 diabetic patients carrying HFE mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15347835     DOI: 10.1385/ENDO:24:2:111

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  32 in total

1.  C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes.

Authors:  T Frayling; S Ellard; J Grove; M Walker; A T Hattersley
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

2.  Prevalence of diabetes and impaired glucose tolerance in Aragón, Spain.

Authors:  B Tamayo-Marco; E Faure-Nogueras; M J Roche-Asensio; E Rubio-Calvo; E Sánchez-Oriz; J A Salvador-Oliván
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

3.  Factors affecting glucose tolerance in hereditary hemochromatosis.

Authors:  I M Hramiak; D T Finegood; P C Adams
Journal:  Clin Invest Med       Date:  1997-04       Impact factor: 0.825

4.  Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes.

Authors:  M J Sampson; T Williams; P J Heyburn; R H Greenwood; R C Temple; J Z Wimperis; B A Jennings; G A Willis
Journal:  J Lab Clin Med       Date:  2000-02

5.  HFE mutations in African-American women with non-insulin-dependent diabetes mellitus.

Authors:  R T Acton; J C Barton; D S Bell; R C Go; J M Roseman
Journal:  Ethn Dis       Date:  2001       Impact factor: 1.847

6.  A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population.

Authors:  Maciej T Małecki; Tomasz Klupa; Małgorzata Waluś; Wojciech Czogała; Paul Greenlaw; Jacek Sieradzki
Journal:  Med Sci Monit       Date:  2003-02

7.  Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study.

Authors:  David J Halsall; Ian McFarlane; Jian'an Luan; Timothy M Cox; Nicholas J Wareham
Journal:  Hum Mol Genet       Date:  2003-06-15       Impact factor: 6.150

Review 8.  Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes.

Authors:  Jurgen Fuchs; M Podda; L Packer; R Kaufmann
Journal:  Toxicology       Date:  2002-11-15       Impact factor: 4.221

9.  Population screening for hemochromatosis: a study in 5370 Spanish blood donors.

Authors:  Mayka Sánchez; Margarita Villa; Mercedes Ingelmo; Cristina Sanz; Miquel Bruguera; Carlos Ascaso; Rafael Oliva
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

10.  A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis.

Authors:  E Cadet; D Capron; A S Perez; S N Crépin; S Arlot; J-P Ducroix; M Dautréaux; P Fardellone; P Leflon; A T Merryweather-Clarke; K J Livesey; J J Pointon; P Rose; J Harcourt; J Emery; J M Sueur; R Feyt; K J H Robson; J Rochette
Journal:  J Intern Med       Date:  2003-02       Impact factor: 8.989

View more
  2 in total

Review 1.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

2.  Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications.

Authors:  J Wong; S V McLennan; L Molyneaux; D Min; S M Twigg; D K Yue
Journal:  Diabetologia       Date:  2009-07-21       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.